Home > PE Ratio > AURO LABORATORIES

AURO LABORATORIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of AURO LABORATORIES is 17.40.

Share Price ₹202.0Apr 24,2024
Market Cap ₹125.2 Cr
Earnings-TTM₹7.2 CrTTM-Standalone Results
Price/Earnings17.40xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for AURO LABORATORIES
Please provide your vote to see the results
AURO LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of AURO LABORATORIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of AURO LABORATORIES is calculated as :

Current Market Cap [ ₹125.2 Cr] as on Apr 24,2024

(/) Earnings [ ₹7.2 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 17.40x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for AURO LABORATORIES , the investors are currently willing to pay 17.40 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of AURO LABORATORIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of AURO LABORATORIES over the last five years.

Historical PE (Price/Earnings) ratio chart of AURO LABORATORIES


PE Ratio Performance Analysis for AURO LABORATORIES

- AURO LABORATORIES 's latest p/e ratio is 17.40x.

- AURO LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 11.24x.

- AURO LABORATORIES 's operated at median p/e ratio of 8.42x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, AURO LABORATORIES 's p/e ratio peaked in Mar2022 at 21.98x.

- AURO LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 4.83x.


How does AURO LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
AURO LABORATORIES 7.1917.40125.2
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6339.63356,625.0
CIPLA LTD3,744.0330.16112,938.0
DR REDDYS LABORATORIES LTD5,209.4019.0699,276.9
ZYDUS LIFESCIENCES LTD2,954.2031.7993,921.9
DIVIS LABORATORIES LTD1,382.9773.26101,315.0
MANKIND PHARMA LTD1,743.3055.1596,143.2
TORRENT PHARMACEUTICALS LTD1,494.0060.8390,872.6
LUPIN LTD1,809.7439.7972,010.8
AUROBINDO PHARMA LTD2,777.8922.8663,492.3
ABBOTT INDIA LTD1,145.5847.2354,105.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs AURO LABORATORIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 17.40x
Max industry PE 73.26x
Median industry PE 39.63x
Average industry PE 39.74x



You may also like the below Video Courses